Skip to content

Research at St Andrews

Using RT qPCR for quantifying Mycobacteria marinum from in vitro and in vivo samples

Research output: Chapter in Book/Report/Conference proceedingChapter

Open Access Status

  • Embargoed (until 11/01/19)

Abstract

Mycobacterium marinum, the causative agent of fish tuberculosis, is rarely a human pathogen causing a chronic skin infection. It is now wildely used as a model system in animal models, especially in zebra fish model, to study the pathology of tuberculosis and as a means of screening new anti-tuberculosis agent. To facilitate such research, quantifying the viable count of M. marinum bacteria is a crucial step. The main approach used currently is still by counting the number of colony forming units (cfu), a method that has been in place for almost 100 years. Though this method well established, understood and relatively easy to perform, it is time-consuming and labor-intensive. The result can be compromised by failure to grow effectively and the relationship between count and actual numbers is confused by clumping of the bacteria where a single colony is made from multiple organisms. More importantly, this method is not able to detect live but not cultivable bacteria, and there is increasing evidence that mycobacteria readily enter a "dormant" state which confounds the relationship between bacterial number in the host and the number detected in a cfu assay. DNA based PCR methods detect both living and dead organisms but here we describe a method, which utilizes species specific Taq-Man assay and RT-qPCR technology for quantifying the viable M. marinum bacterial load by detecting 16S ribosomal RNA (16S rRNA).
Close

Details

Original languageEnglish
Title of host publicationAntibiotic Resistance Protocols
EditorsStephen Gillespie
Place of PublicationNew York, NY
PublisherHumana Press/Springer
Pages137-145
Number of pages9
ISBN (Electronic)9781493976386
ISBN (Print)9781493976362
DOIs
StatePublished - 2018

Publication series

NameMethods in Molecular Biology
PublisherHumana Press
Volume1736
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study

    Murphy, M. E., Wills, G. H., Murthy, S., Louw, C., Bateson, A. L. C., Hunt, R. D., McHugh, T. D., Nunn, A. J., Meredith, S. K., Mendel, C. M., Spigelman, M., Crook, A. M., Gillespie, S. H. & REMoxTB Consortium 17 Oct 2018 In : BMC Medicine. 16, 11 p., 189

    Research output: Contribution to journalArticle

  2. Phenotypic changes on Mycobacterium tuberculosis-specific CD4 T cells as surrogate markers for tuberculosis treatment efficacy

    Ahmed, M. I. M. , Ntinginya, N. E. , Kibiki, G. , Mtafya, B. A. , Semvua, H. , Mpagama, S. , Mtabho, C. , Saathoff, E. , Held, K. , Loose, R. , Kroidl, I. , Chachage, M. , Both, U. V. , Haule, A. , Mekota, A-M. , Boeree, M. J. , Gillespie, S. H. , Hoelscher, M. , Heinrich, N. , Geldmacher, C. & 1 others Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) 28 Sep 2018 In : Frontiers in Immunology. 9, 13 p., 2247

    Research output: Contribution to journalArticle

  3. Centrifugation and decontamination procedures selectively impair recovery of important populations in Mycobacterium smegmatis

    Kennedy, J. A., Baron, V. O., Hammond, R. J. H., Sloan, D. J. & Gillespie, S. H. 1 Aug 2018 In : Tuberculosis.

    Research output: Contribution to journalArticle

  4. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Crook, A. M., Amukoye, E. I., Dawson, R., Diacon, A. H., Hanekom, M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murphy, M. E., Murthy, S. E., Nunn, A. J., Phillips, P. P. J., Singh, K. P., Spigelman, M., Wills, G. H. & Gillespie, S. H. 11 Jul 2018 In : BMC Infectious Diseases. 18, 11 p., 317

    Research output: Contribution to journalArticle

ID: 252482706